Structures by: Jabli H.
Total: 5
3-Allyl-1,5-dibenzyl-1,5-benzodiazepine-2,4-dione
C26H24N2O2
Acta Crystallographica Section E (2009) 65, 12 o3150
a=9.2603(4)Å b=14.0037(6)Å c=16.2249(7)Å
α=90.00° β=91.9960(10)° γ=90.00°
1,5-Dibenzyl-3-propargyl-1,5-benzodiazepine-2,4-dione
C26H22N2O2
Acta Crystallographica Section E (2009) 65, 12 o3149
a=8.8663(2)Å b=18.6771(4)Å c=12.4665(3)Å
α=90.00° β=91.1540(10)° γ=90.00°
4-[(1,5-Dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin- 3-yl)methyl]-1-<i>n</i>-octyl-1<i>H</i>-1,2,3-triazole
C34H39N5O2
Acta Crystallographica Section E (2010) 66, 1 o231
a=9.1797(2)Å b=10.4238(2)Å c=31.4716(7)Å
α=90.00° β=90.00° γ=90.00°
1-(12-Azido-<i>n</i>-dodecyl)-4-[(1,5-dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-\ 1<i>H</i>-1,5-benzodiazepin-3-yl)methyl]-1<i>H</i>-1,2,3-triazole
C38H46N8O2
Acta Crystallographica Section E (2010) 66, 1 o232
a=9.4269(2)Å b=12.3304(3)Å c=15.5500(4)Å
α=101.121(2)° β=92.175(2)° γ=92.935(2)°
Ethyl 2-{4-[(1,5-dibenzyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5- benzodiazepin-3-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C30H29N5O4
Acta Crystallographica Section E (2010) 66, 1 o126
a=14.2015(5)Å b=10.9337(4)Å c=17.9368(6)Å
α=90.00° β=95.699(2)° γ=90.00°